Catalyst Wire Dossier Catalyst Wire Dossier

Revita DMR

· Fractyl Health Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Revita DMR, covering 2025-03-14 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Safety and Efficacy of Revita® DMR on Body Weight Maintenance in Subjects With Obesity Who Have Achieved at Least 15% Weight Loss on Tirzepatide [NA]

See pricing